FRANKFURT, March 24 (Reuters) - Glaxosmithkline said
that Moncef Slaoui has been dismissed as chairman of Galvani
Bioelectronics, which is majority owned by GSK.
GSK said the termination of Slaoui's contract was with
immediate effect. Slaoui was not immediately available for
comment.
(Reporting by Ludwig Burger, editing by Louise Heavens)